Wall Street Loves These Stocks. Should You?

Generics already account for more than three-quarters of all prescriptions written today, and by 2015, blockbuster drugs with annual sales of $170 billion will go off patent. If you're looking for a stock that will ride out the boom and bust of business cycles, Teva seems particularly then-suited to the task.

CAPS member talan123 likes the fact that Teva as well has branded products of its own, and although that raises an ironic twist in that it will as well face the loss of patent protection on drugs like Copaxone, it as well means it has a diversified business line that can weather the ups and downs of volatility.

Going for the win Rural telecom provider Windstream found itself caught in a gale of higher overhead costs outpacing gains made in sales. However with 16% fewer customer connections across its voice, digital TV, and high-speed Internet access business lines, it looks like it will continue to swim against the tide.

As mobile communications grow, the importance of its landline business diminishes, even in rural areas. Rivals Frontier Communications and CenturyLink witnessed the same challenges of trying to emphasize higher-margin services like broadband Internet to their traditional landline clients. Windstream however saw a 27% drop in net high-speed Internet additions in the quarter.

CAPS member S4Aero believes the telecom however has a solid business plan for growth, and he'll await its fruition during collecting the dividend, which currently yields 8%.

Solid service and a plan for the future to move into VoIP (Voice over Internet Protocol) and expand their cloud and broadband offerings. The biggest risk is in the continued erosion of landline home phone service, nevertheless replacement as indicated should more than offset that change.